poisar

Stocks · News reference

SANUWAVE Health Q2 EPS $(0.08) Down From $(0.04) YoY, Sales $9.739M Down From $10.054M YoY

Benzinga Newsdesk

SANUWAVE Health (NASDAQ:SNWV) reported quarterly losses of $(0.08) per share. This is a 100 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $9.739 million in sales

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

SNWV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    Sanuwave Announces Q2 FY2026 Financial Results

    Sanuwave Health (NASDAQ: SNWV) reported Q2 2026 revenues of $9.7 million, down 3% year-over-year, with gross margins declining to 76.2% from 78.1%. The company posted an operating loss of $0.3 million versus operating income of $1.4 million in Q2 2025. While Ultramist applicator revenue grew 13%, system sales declined significantly due to CMS reimbursement pressures and a secondary market for used equipment. The company has withdrawn its 2026 guidance pending clarity on Medicare reimbursement developments.

    SNWV
  2. SEC EDGAR

    8-K filing — SANUWAVE Health, Inc. (SNWV)

    Filed: 2026-08-06 AccNo: 0001628280-26-054459 Size: 502 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

    SNWV